Literature DB >> 33172858

Response to 'Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'' by Shi et al.

Shintaro Akiyama1, Shadi Hamdeh2, Dejan Micic1, Atsushi Sakuraba3.   

Abstract

Entities:  

Keywords:  Covid-19; autoimmune diseases; epidemiology

Year:  2020        PMID： 33172858     DOI： 10.1136/annrheumdis-2020-219394

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  12 in total

Review 1.  [Biologics for connective tissue diseases and vasculitides].

Authors:  Bernhard Hellmich; Joerg C Henes
Journal:  Internist (Berl)       Date:  2022-01-14       Impact factor: 0.743

2.  A Mendelian randomization study of genetic predisposition to autoimmune diseases and COVID-19.

Authors:  Shun Li; Shuai Yuan; C M Schooling; Susanna C Larsson
Journal:  Sci Rep       Date:  2022-10-21       Impact factor: 4.996

3.  Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases.

Authors:  Claire T Deakin; Georgina H Cornish; Kevin W Ng; Nikhil Faulkner; William Bolland; Joshua Hope; Annachiara Rosa; Ruth Harvey; Saira Hussain; Christopher Earl; Bethany R Jebson; Meredyth G L L Wilkinson; Lucy R Marshall; Kathryn O'Brien; Elizabeth C Rosser; Anna Radziszewska; Hannah Peckham; Harsita Patel; Judith Heaney; Hannah Rickman; Stavroula Paraskevopoulou; Catherine F Houlihan; Moira J Spyer; Steve J Gamblin; John McCauley; Eleni Nastouli; Michael Levin; Peter Cherepanov; Coziana Ciurtin; Lucy R Wedderburn; George Kassiotis
Journal:  Med (N Y)       Date:  2021-08-14

Review 4.  Benefit-risk evaluation of COVID-19 vaccination in special population groups of interest.

Authors:  Paul Moss; Francis Berenbaum; Giuseppe Curigliano; Ayelet Grupper; Thomas Berg; Shanti Pather
Journal:  Vaccine       Date:  2022-05-27       Impact factor: 4.169

5.  Is SARS-CoV-2 screening test indicated for psoriasis patients candidate to biologic therapy?

Authors:  S Piaserico; P Gisondi; S Cazzaniga; G Girolomoni; P G Calzavara-Pinton; L Naldi
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-03-05       Impact factor: 9.228

6.  The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?

Authors:  S Sen; R Karabudak; I Schiavetti; S Demir; S Ozakbas; M Tutuncu; B Petek Balci; O F Turan; C Uzunkopru; M Koseoglu; M F Yetkin; T Gunduz; H Gumus; N Kale Icen; L Carmisciano; M Terzi; P Acar; I Gungor Dogan; C Baba; A Tuncer; U Uygunoglu; M P Sormani; H Efendi; A Siva
Journal:  Mult Scler Relat Disord       Date:  2021-04-18       Impact factor: 4.808

7.  Severity and mortality of COVID-19 in patients with systemic sclerosis: a Brazilian multicenter study.

Authors:  Sandra Maximiano de Oliveira; Lucas Victória de Oliveira Martins; Ana Paula Lupino-Assad; Ana Cristina Medeiros-Ribeiro; Daniela Aparecida de Moraes; Ana Paula Toledo Del-Rio; Maria Carolina Oliveira; Percival Degrava Sampaio-Barros; Cristiane Kayser
Journal:  Semin Arthritis Rheum       Date:  2022-02-25       Impact factor: 5.431

8.  Prevalence of coronavirus disease 2019 in a multiethnic cohort of patients with autoimmune rheumatic diseases in Qatar.

Authors:  Karima Becetti; Eman Satti; Betsy Varughese; Yousef Al Rimawi; Rawan Sheikh Saleh; Nawal Hadwan; Miral H Gharib; Mohamed Awni Al Kahlout; Essa Abuhelaiqa; Hadil Afif Ashour; Rajvir Singh; Samar Al Emadi
Journal:  Qatar Med J       Date:  2022-08-05

9.  Outcomes of COVID-19 in Inflammatory Rheumatic Diseases: A Retrospective Cohort Study.

Authors:  Thamer Saad Alhowaish; Moustafa S Alhamadh; Abdulrahman Yousef Alhabeeb; Shaya Fahad Aldosari; Emad Masuadi; Abdulrahman Alrashid
Journal:  Cureus       Date:  2022-06-26

Review 10.  The Influence of Corticosteroids, Immunosuppressants and Biologics on Patients With Inflammatory Bowel Diseases, Psoriasis and Rheumatic Diseases in the Era of COVID-19: A Review of Current Evidence.

Authors:  Mengyuan Zhang; Xiaoyin Bai; Wei Cao; Junyi Ji; Luo Wang; Yang Yang; Hong Yang
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.